Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-24 @ 11:45 PM
NCT ID:
NCT06323551
Eligibility Criteria:
Inclusion Criteria:
* Term newborns receiving treatment in Mersin City Training and Research Hospital Neonatal Intensive Care Service,
* Postnatal 1-15. Newborns on their day,
* Newborns who have not previously used any pharmacological or non-pharmacological method for pain management,
* Newborns with an Apgar score of 8 points or more at the 1st and 5th minutes,
* Not having undergone a surgical procedure,
* Does not have any health problems,
* Patients whose families approve the informed consent form.
Exclusion Criteria:
* Born before 37 weeks of gestation, receiving treatment in the Neonatal Intensive Care Service at Mersin City Training and Research Hospital,
* Sedation area
* Except for major congenital anomaly
* Older than the 15th postnatal day,
* Having a major anomaly or disease detected antenatally,
* Patients with comorbid diseases such as perinatal asphyxia, bronchopulmonary dysplasia, intraventricular hemorrhage, necrotizing enterocolitis, congenital heart disease and similar diseases,
* Patients whose families do not give consent will not be included in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
15 Days
Study:
NCT06323551
Study Brief:
Protocol Section:
NCT06323551